Immunome, Inc.IMNMNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+131.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+131.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
67.1x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$50.69M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$755000.00+22.8%
2019$615000.00+18.0%
2018$521000.00-